Ciclosporin - Transplant immunosuppression
You are here : Home > Formulary Search > Ciclosporin - Transplant immunosuppression
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Blue
Formulations :
- Not Specified
Formulary Status :
Restrictions / Comments :
Important
For EXISTING patients only: GPs may continue to prescribe for existing post-transplant patients only. MHS England are looking to repatriate the patients in the future. GPs must not accept requests to prescribe for new patients.
Status 2
Red
Formulations :
- Capsules
- Oral solution
Formulary Status :
Restrictions / Comments :
Important
For NEW patients: RED drug for post-transplant. Funded by NHS England. GPs should not accept any new requests to prescribe post-transplant.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Ciclosporin
Indication :
Transplant immunosuppression
Group Name :
Keywords :
Brand Names Include :
Neoral, Sandimmun
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2
Other Indications
Below are listed other indications that Ciclosporin is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Transplant immunosuppression.
Committee Recommendations (1)
01 Apr 13 -
Not Set
FOR EXISTING PATIENTS: GPs should continue to prescribe these treatments. NHS England are looking to repatriate these patients in the future. The Medicines Management Team will be in contact with prescribers when they have more information
FOR NEW PATIENTS ONLY: The prescribing of Ciclosporin is considered a RED drug post transplant only and is now funded via NHS England for this indication.
FOR NEW PATIENTS ONLY: The prescribing of Ciclosporin is considered a RED drug post transplant only and is now funded via NHS England for this indication.